Built for Uptime: How PBSC Transfer Hatches Support Cleanroom Reliability

Why Uptime Matters: Operational and Financial Risks

Pharmaceutical laboratories and manufacturing facilities face major risks from unplanned downtime – disruptions that halt operations, increase costs and threaten product integrity. Even short interruptions can idle staff, spoil materials or delay the release of time-sensitive batches. Industry data highlights the scale of the issue,

  • 73% of lab professionals identify unplanned downtime as a leading barrier to productivity.
  • 60% of laboratories experience significant downtime due to equipment failures, missed calibrations, or asset location issues [1].

Such disruptions can reduce operational capacity by more than 10% in mid-to-large laboratories [2], resulting in higher labour costs, emergency repairs and compromised batch quality.

Regulatory Drivers: EU GMP Annex 1 and FDA GuidancePBSC wall-mounted transfer hatch with open toughened glass door showing passive mechanical interlock bar, stainless steel frame, green status indicator and glass shelf installed in a cleanroom

Regulatory frameworks underline the need to minimise contamination risk. The revised EU GMP Annex 1 (2023) requires pass-through hatches with interlocked doors to protect higher-grade areas and maintain pressure differentials in aseptic zones. Sections 4.14–4.15 specify interlocks and active air flushing where appropriate. Similarly, FDA guidance on aseptic processing stresses validated environmental controls and interlocked airlocks to reduce contamination risk and avoid costly reworks or rejected batches.

Designed to Support Operations During Power Loss

Mitigating these setbacks depends on equipment that delivers dependable performance together with a planned maintenance programme. PBSC transfer hatches are engineered to support critical workflows – including continued protection during power outages.

Passive Mechanical Interlocks: Durable, Fail-Safe Protection

PBSC’s mechanical interlock is housed between two hatch skins and functions entirely without power. This passive, fail-safe design provides continuous protection even during power loss. The concealed mechanism reduces opportunities for accidental or unauthorised tampering and enforces strict sequential door operation, preserving cleanroom pressure cascades and area segregation. Its robust, low-maintenance construction lowers the likelihood of unexpected failures and supports regulatory compliance while contributing to uptime.

Electronic Control Options: Enhanced Flexibility with Automation

Where automation is required, PBSC’s electronic interlock systems offer additional capability. The control panel supports adjustable time delays for purge cycles, UV disinfection or pressure stabilisation and provides visual indicators on both sides for quick status checks. Systems can integrate with Building Management Systems (BMS), aligning with validated workflows common in pharmaceutical, biotech and high-containment facilities. This level of automation helps deliver repeatable performance and supports traceability for compliance records.

Proactive Maintenance: The Key to Minimising Downtime

Although PBSC transfer hatches are built for longevity, planned preventive maintenance is essential to reduce the risk of unplanned downtime. Evidence shows structured maintenance programmes significantly reduce failure rates, extend operational uptime and improve readiness for audits.

PBSC’s tailored service offerings include regular inspections, calibration and performance checks to ensure your hatches remain compliant and perform as intended. Protect your cleanroom – and your productivity – by partnering with PBSC for proactive care.

PBSC Planned Preventive MaintenancePharmaceutical cleanroom interior showing a wall-mounted transfer hatch, freestanding pass-through unit, double-door airlock and stainless steel lockers and bench

Learn more about our maintenance and servicing options

PBSC Planned Preventive Maintenance

[1] M. Filbin et al, Critical Care Medicine 2018; 46:1592–1599, Editorial Team. Consequences of Unplanned Downtime in the Laboratory, Beckman Coulter Diagnostics. Beckman Coulter. Published 2021 February.

[2] Pharmaceutical Technology, “Lab Downtime Impacts and Mitigation,” 2023.

Disclaimer

This document is provided for general information only. While PBSC designs and supplies high-quality equipment for cleanroom and containment environments, we do not provide regulatory, operational or compliance advice. For guidance specific to your facility or regulatory obligations, consult a qualified industry advisor or the appropriate regulatory authority.